SCHEMBL21499680

SCHEMBL21499680

CN1c2nc(Oc3ccccc3)n(Cc3ccc(F)cc3)c2C(=O)N(CCCO)C1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 7/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ TSHR P16473 3/20 0.39
▸ USP2 O75604 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ TRPC4 Q9UBN4 2/20 0.39
▸ TRPC5 Q9UL62 2/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.38
▸ TRPC1 P48995 1/20 0.38
▸ POLB P06746 1/20 0.35
▸ MAPK1 P28482 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HRH1 P35367 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20432022 0.92 TRPC4 (0.42) P2RX3TRPC4TRPC5KCNH2TRPC1
SCHEMBL19505572 0.92 TRPC4 (0.47) P2RX3TRPC4TRPC5KCNH2ADORA3
SCHEMBL19375398 0.91 P2RX3 (0.38) P2RX3ALDH1A1TSHRUSP2CYP1A2
SCHEMBL19375181 0.90 TRPC5 (0.41) P2RX3ALDH1A1TSHRUSP2CYP1A2
SCHEMBL20432432 0.90 PDE5A (0.37) P2RX3ALDH1A1TSHRUSP2CYP1A2
SCHEMBL18833918 0.90 P2RX3 (0.35) P2RX3ALDH1A1TSHRCYP1A2CYP3A4
SCHEMBL19375436 0.89 P2RX7 (0.35) P2RX3TSHRTRPC4TRPC5KCNH2
SCHEMBL19375600 0.87 P2RX3 (0.34) P2RX3TSHRTRPC4TRPC5KCNH2
SCHEMBL18834916 0.87 TRPC4 (0.45) P2RX3TRPC4TRPC5KCNH2TRPC1
SCHEMBL18835341 0.86 TRPC4 (0.41) ALDH1A1TSHRTRPC4TRPC5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2023-02-09 — — US disclosed
US-11208409-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2021-12-28 — — US disclosed
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 P2RX3 30/4885ALDH1A1 1647/4885TSHR 4540/4885
US-11208409-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 P2RX3 30/4885ALDH1A1 1647/4885TSHR 4540/4885
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 P2RX3 30/4885ALDH1A1 1647/4885TSHR 4540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback